EE658 Cost-Effectiveness of Nivolumab in Combination With Platinum Doublet Chemotherapy (PDC) for the Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer in Slovenia
20240 citationsJournal Articlebronze Open Access
Field-Weighted Citation Impact: 0.00
EE658 Cost-Effectiveness of Nivolumab in Combination With Platinum Doublet Chemotherapy (PDC) for the Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer in Slovenia | Researchclopedia